Stromal responses amongcommoncarcinomas correlated with clinicopathologic features

Julia L.Y. Chen, Iñigo Espinosa, Albert Y. Lin, Olivia Y.W. Liao, Matt Van De Rijn, Robert B. West

Research output: Contribution to journalArticleResearchpeer-review

15 Citations (Scopus)


Purpose: We have previously characterized a tumor stroma expression signature in a subset of breast tumors that correlates with better clinical outcome. The purpose of this study is to determine whether this stromal signature, termed the "DTF fibroblast" (desmoid-type fibromatosis) signature, is specific to breast cancer or is a common stromal response found in different types of cancer. Experimental Designs: The DTF fibroblast signature was applied to gene expression profiles from five ovarian, five lung, two colon, and three prostate cancer expression microarray datasets. In addition, two different tissue microarrays of 204 ovarian tumors and 140 colon tumors were examined for the expression of previously characterized protein markers of DTF fibroblast signature. The DTF fibroblast stromal response was then correlated with clinicopathologic features. Results: The DTF fibroblast signature is robustly present in ovarian, lung, and colon carcinomas. Both expression microarray data and immunohistochemistry show that the subset of ovarian tumors with strong DTF fibroblast signature expression has statistically significant, worse survival outcomes. No reproducible survival differences were found in either the lung or the colon cancers. The prostate cancers failed to show a DTF fibroblast signature. Multivariant analysis showed that DTF fibroblast signature was significantly more prognostic than the proliferation status in ovarian carcinomas. Conclusions: Our results suggest that the DTF fibroblast signature is a common tumor stroma signature in different types of cancer, including ovarian, lung, and colon carcinomas. Our findings provide further insight into the DTF fibroblast stromal responses across different types of carcinomas and their potential as prognostic and therapeutic targets. © 2013 American Association for Cancer Research.
Original languageEnglish
Pages (from-to)5127-5135
JournalClinical Cancer Research
Issue number18
Publication statusPublished - 15 Sep 2013


Dive into the research topics of 'Stromal responses amongcommoncarcinomas correlated with clinicopathologic features'. Together they form a unique fingerprint.

Cite this